Itron (ITRI) is a Technology company in the Scientific Technical Instruments industry. It has a market capitalization of $4.32B, a trailing price-to-earnings ratio of 13.2 and a free-cash-flow yield of 8.4%. Over the most recent reported fiscal year, revenue declined 3.0% and free cash flow per share grew 84.0%. Nama's AI scorecard rates it Buy, 6.9 out of 10. On 12-month momentum it ranks in the trailing band of its market.
AI scorecard
Buy · 6.9/10
Positive, at the low end of Buy. As of Nov 7, 2026.
Momentum
Trailing · -19.3% over 12 months ex. last
Bottom 20% of its market on the past year's move.
Shariah screen
Not Shariah Compliant
At least one of the three ratios or the industry test failed.
Off its high
-30.7%
How far the last close sits under the highest price of the past five years.
Market cap
$4.32B
Trailing P/E
13.2
Price / book
2.5
Price / sales
1.9
FCF yield
8.4%
Dividend yield
—
Gross margin
38.8%
Operating margin
13.0%
Net margin
12.3%
Revenue growth (YoY)
-3.0%
Revenue growth (3-yr annual)
+9.7%
EPS growth (YoY)
+26.6%
FCF/share growth (YoY)
+84.0%
Beta
1.3
Exchange
NASDAQ
Sector
Technology
Industry
Scientific Technical Instruments
ITRI earnings
Next report: Feb 16, 2027 (Q4 2026, EPS estimate $1.75).
Beat the EPS estimate in 4 of 4 recent quarters.
Quarter
Reported
EPS
Estimate
Surprise
Revenue
Q3 2026
Oct 27, 2026
$1.94
$1.56
+24.4%
$599.33M
Q2 2026
Jul 28, 2026
$1.59
$1.29
+23.3%
—
Q1 2026
Apr 28, 2026
$1.49
$1.24
+20.2%
$586.98M
Q4 2025
Feb 17, 2026
$2.46
$2.19
+12.3%
$571.66M
ITRI analyst price target
Median target $130.00 from 9 analysts, ranging $105.00 – $150.00.
Nama's AI scorecard currently rates Itron Buy (6.9 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is ITRI's P/E ratio?
Itron trades at a trailing price-to-earnings ratio of 13.2.
When does ITRI report earnings?
Itron's next scheduled report is on Feb 16, 2027. Analysts expect EPS of $1.75.
What is the ITRI price target?
The median analyst price target from 9 analysts is $130.00, with a range of $105.00 – $150.00.
Is ITRI Shariah compliant?
Nama's AAOIFI-style screen reads Itron as Not Shariah Compliant. At least one of the three ratios or the industry test failed.